June 6, 2018
Yakult Honsha announced on June 5 that it has signed an exclusive license agreement to develop and commercialize Verastem’s anticancer drug duvelisib for the treatment, prevention, and diagnosis of all oncology indications in Japan. The US biopharma is seeking approval...read more